Prothena: Trial data underscores the potential of antibody in treating Alzheimer’s disease

cafead

Administrator
Staff member
  • cafead   Feb 01, 2023 at 10:32: AM
via Biotechnology company, Prothena, has announced positive topline Phase 1 SAD study results for PRX005, an investigational tri-epitopic antibody for the treatment of Alzheimer’s disease.

article source